Cargando…
Latest perspectives of orally bioavailable 2,4-diarylaminopyrimidine analogues (DAAPalogues) as anaplastic lymphoma kinase inhibitors: discovery and clinical developments
The course of anaplastic lymphoma kinase (ALK)-rearranged non-small-cell lung cancer (NSCLC) therapy has improved impressively. The Food and Drug Administration (FDA) has approved crizotinib (Xalkori, Pfizer) as a first-in-class tyrosine kinase inhibitor (TKI) that demonstrated a substantial objecti...
Autores principales: | Latif, Muhammad, Ashraf, Zaman, Basit, Sulman, Ghaffar, Abdul, Zafar, Muhammad Sohail, Saeed, Aamer, Meo, Sultan Ayoub |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9080316/ https://www.ncbi.nlm.nih.gov/pubmed/35540549 http://dx.doi.org/10.1039/c8ra01934g |
Ejemplares similares
-
A Smart Drug Delivery System Based on Biodegradable Chitosan/Poly(allylamine hydrochloride) Blend Films
por: Sarwar, Muhammad Sohail, et al.
Publicado: (2020) -
The role of chemotherapy and latest emerging target therapies in anaplastic thyroid
cancer
por: Denaro, Nerina, et al.
Publicado: (2013) -
Trehalose Analogues: Latest Insights in Properties and Biocatalytic Production
por: Walmagh, Maarten, et al.
Publicado: (2015) -
ChatGPT Knowledge Evaluation in Basic and Clinical Medical Sciences: Multiple Choice Question Examination-Based Performance
por: Meo, Sultan Ayoub, et al.
Publicado: (2023) -
Augmented Oral Bioavailability and Prokinetic Activity of Levosulpiride Delivered in Nanostructured Lipid Carriers
por: Arif, Sadia Tabassam, et al.
Publicado: (2022)